Search the Newsreel

RGC|Regencell Bioscience Holdings Ltd|Price:5.770|Chg%:+0.050

This article provides a comprehensive stock analysis of Regencell Bioscience Holdings Ltd (RGC) from TradingKey, noting the lack of a stock score due to insufficient data. It details how TradingKey generates various scores, including financial health, company valuation, earnings forecasts, price momentum, institutional confidence, …

Regencell Bioscience Holdings Ltd (RGC) Income Statement

This article provides the quarterly and annual income statements for Regencell Bioscience Holdings Ltd (RGC), offering insights into the company's financial performance and operational efficiency. It details key metrics such as operating expenses, R&D expenses, operating profit, and net income over several fiscal periods, …

Regencell Bioscience Holdings Ltd RGC Balance Sheet

This article provides a detailed balance sheet for Regencell Bioscience Holdings Ltd (RGC), presenting both quarterly and annual financial data spanning several fiscal years. It includes key financial metrics such as total equity, cash and short-term investments, total assets, liabilities, and shareholders' equity. The …

RGC Resources to Review Fiscal Q3 Results in Aug. 7 Webcast

RGC Resources, Inc. (Nasdaq: RGCO) will host a conference call and webcast on Friday, August 7, 2026, at 9:00 a.m. Eastern time to discuss its fiscal third-quarter 2026 results. Investors can access the call via a toll-free dial-in number or webcast, with related presentation …

RGCO|RGC Resources Inc|Price:22.000|Chg%:-0.120

This article provides a comprehensive stock analysis of RGC Resources Inc (RGCO) by TradingKey. It highlights that RGCO has healthy fundamentals, high growth potential, and is considered fairly valued. Despite recent weak stock market performance, the company shows strong fundamentals and institutional confidence, with …

RGC Resources Inc Today's Market Trends | RGCO Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

This article provides an in-depth analysis of RGC Resources Inc (RGCO), detailing its latest market trends, financial performance, and analyst ratings. It highlights the company's strong fundamentals and high growth potential, despite recent stock market performance. The report also includes key figures, score analysis, …

Rgc Resources Inc. (RGCO) Q2 2023 Earnings Report - Results, Call & Slides

Rgc Resources Inc. (RGCO) reported its Q2 2023 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of $0.64 against a consensus of $0.58, and actual revenue of $38.03M compared to an expected $32.00M, representing a 28.78% year-over-year revenue growth. …

Regencell Bioscience (NASDAQ:RGC) Stock Price Down 7.2% - Time to Sell?

Regencell Bioscience (NASDAQ:RGC) stock fell 7.2% on Wednesday, with trading volume significantly lower than average. Analyst sentiment remains negative, with both Wall Street Zen and Weiss Ratings issuing "sell" recommendations. The stock is trading well below its 50-day and 200-day moving averages, indicating a …

RGC Resources (RGCO) Q2 2026 earnings summary

RGC Resources (RGCO) announced a strong Q2 2026 with net income rising 14% year-over-year to $8.7 million on operating revenues of $45.5 million, marking a 25% increase. The company's six-month net income also grew by 5.3% to $13.6 million, driven by higher operating margins, …

RGC Resources (RGCO) Investor presentation Summary

This article summarizes RGC Resources' (RGCO) investor presentation from May 21, 2026. It highlights the company's structure as a utility holding company with Roanoke Gas and RGC Midstream, recent operational achievements like record annual send out and expedited rate case benefits, and its stable …

Regencell Bioscience (NASDAQ:RGC) Trading 12% Higher - Should You Buy?

Regencell Bioscience (NASDAQ:RGC) experienced a 12% jump in its share price on Tuesday, trading as high as $5.67 before closing at $5.71, despite a significant drop in trading volume. This surge occurs against a backdrop of negative analyst ratings, with Weiss Ratings reiterating a …

Regencell Bioscience stock hits 52-week low at 4.91 USD By Investing.com

Regencell Bioscience Holdings Ltd (RGC) stock has plummeted to a 52-week low of $4.91, marking a 66.02% decline over the past year and an 81% drop in the last six months. Despite trading near its low, InvestingPro rates the company's financial health as "WEAK" …

RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Regencell Bioscience Holdings Ltd. to Contact the Firm Today!

Bronstein, Gewirtz and Grossman, LLC has filed a class action lawsuit against Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) on behalf of investors who purchased securities between October 28, 2024, and October 31, 2025. The lawsuit alleges that Regencell made materially false and misleading statements, exposing …

RGC Resources Inc. (RGCO) Edges Lower Amid Modest Trading Activity - Ichimoku Kumo Break

RGC Resources Inc. (RGCO) Edges Lower Amid Modest Trading Activity - Put Call Ratio

Regencell Bioscience Holdings Ltd (RGC) volume expands into a sharp weekly selloff

Weekly market data show heavier participation as the healthcare name remains weak across one-, four-, and twelve-week measures.

Regencell Bioscience Holdings Ltd (RGC) volume swells as weekly slide deepens

The healthcare name is under broad pressure across one-, four- and twelve-week measures, with trend and strength readings still weak.

Regencell Bioscience Holdings Ltd (RGC) loses 46.0% in one week

The retreat stands out because turnover expanded sharply while momentum measures remained weak.

Regencell Bioscience Holdings Ltd (RGC) volume swells as weekly selling accelerates

The healthcare stock’s reversal is being confirmed by heavier turnover and weak momentum readings in weekly context.

HEIDELBERG Forecast — Price Target — Prediction for 2027

Regencell Bioscience Holdings Ltd (RGC) loses 53.4% over four weeks

The healthcare stock’s selloff has deepened with turnover above normal and technical readings still pointing to pressure.

Regencell Bioscience Holdings Ltd (RGC) sits in a 53.4% four-week drawdown

The latest weekly close left the healthcare name with weak momentum readings and an inactive trend state.

Regencell Bioscience Holdings Ltd (RGC) weekly slide deepens with volume pressure

The healthcare name is trading with weak trend confirmation after losses broadened across the one-, four- and twelve-week windows.

HeidelbergCement India Share Price Target 2026: Rs 180 Analyst Forecast

HeidelbergCement India posts 25.5% PAT growth in FY26

HeidelbergCement India's profit falls over 10% to ₹45.21 crore in Q4 FY26

HeidelbergCement India Q4: Profit falls 10% despite revenue growth; margin contracts

HeidelbergCement India standalone net profit declines 10.39% in the March 2026 quarter

HEIDELBERG: Revenue and profit rose, dividend declared, and key mining leases secured amid cost optimization

HeidelbergCement India Opens Special Window for Physical Share Transfers

HeidelbergCement India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

HeidelbergCement India Reports No Physical Share Transfer Requests for February 2026

HeidelbergCement India's (NSE:HEIDELBERG) Shareholders Will Receive A Smaller Dividend Than Last Year

HeidelbergCement India's profit rises 20.8% to ₹48.23 crore in Q1 FY26

HeidelbergCement India Q4 profit dips but revenue up; declares dividend of ₹7

Latest News | HeidelbergCement India Q3 Profit Down 83.5 Pc to Rs 5.19 Cr, Sales Down 10.6 Pc